Matthew M. Walsh
2018
In 2018, Matthew M. Walsh earned a total compensation of $10.5M as Chief Financial Officer at Allergan.
Compensation breakdown
| Bonus | $700,000 |
|---|---|
| Non-Equity Incentive Plan | $1,360,545 |
| Salary | $673,846 |
| Stock Awards | $7,807,519 |
| Total | $10,541,910 |
Walsh received $7.8M in stock awards, accounting for 74% of the total pay in 2018.
Walsh also received $700K in bonus, $1.4M in non-equity incentive plan and $673.8K in salary.
Rankings
In 2018, Matthew M. Walsh's compensation ranked 621st out of 14,244 executives tracked by ExecPay. In other words, Walsh earned more than 95.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 621 out of 14,244 | 96th |
Division Manufacturing | 199 out of 5,758 | 97th |
Major group Chemicals And Allied Products | 55 out of 2,119 | 97th |
Industry group Drugs | 43 out of 1,808 | 98th |
Industry Pharmaceutical Preparations | 31 out of 1,382 | 98th |
Source: SEC filing on March 22, 2019.
Walsh's colleagues
We found five more compensation records of executives who worked with Matthew M. Walsh at Allergan in 2018.